Introduction {#sec1-1}
============

**What was known?**

Baboon syndrome or symmetrical drug.-related intertriginous and flexural exanthema. may be induced by systemic administration of substances including contact allergens such as mercury and nickel, and multiple drugs.

Baboon syndrome (or systemically induced allergic contact dermatitis) is characterized by the occurrence of diffuse and symmetric erythematous maculopapular eruption of the flexural areas, with a V-shaped pattern on the medial thighs and diffuse erythema on the buttocks.\[[@ref1]--[@ref5]\] It appears within a few days after systemic administration of substances including contact allergens such as mercury and nickel, and drugs.\[[@ref1]--[@ref5]\] We report here a rare case of baboon syndrome induced by hydroxyzine.

Case Report {#sec1-2}
===========

A 60-year-old man started treatment with hydroxyzine (Atarax^®^; UCB Pharma, France) and meprobamate (Equanil^®^; Sanofi-Aventis, France) for anxiety. Previously, he had taken frequently hydroxyzine without any incident. After 2 days, he developed a pruritic symmetrical erythema with few small pustules on both inner thighs, cubital fossae, axillae, and the gluteal area \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. The patient denied any intake of other medications during the previous weeks and had no history of mercury exposure. There was no fever and laboratory tests (complete blood cell count and C-reactive protein) showed only eosinophilia (800/ml). Blood and pustule cultures were negative. The mycological examination of a pustule was negative. A baboon-type drug reaction was suspected. Skin biopsy showed a perivascular lymphohistiocytic infiltrate with eosinophils and some neutrophils in the dermis. Some subcorneal pustules were also seen. The clinical and histopathological findings were consistent with a pustular drug-related baboon syndrome. The two drugs were discontinued and the lesions resolved within 4 days without any medications. One week later and despite our recommendations, the patient took again one tablet of hydroxyzine. Few hours after restarting therapy, an acute episode of baboon syndrome developed. Hydroxyzine was stopped and the lesions resolved within 1 week. One month after complete resolution, the patient was patch tested with European standard series, metals series, ethylenediamine dihydrochloride (1% pet.), meprobamate (30% pet. and 30% in water), hydroxyzine (30% pet. and 30% in water), cetirizine (30% pet. and 30% in water), and levocetirizine (30% pet. and 30% in water).\[[@ref4]\] Reactions were evaluated at D2 and D3 according to ICDRG guidelines. Only the patch tests with hydroxyzine were positive at D2 (+) and D3 (++). At D4, the positive patch test with hydroxyzine (30% pet.) showed pustular formation \[[Figure 3](#F3){ref-type="fig"}\]. Oral provocation tests with cetirizine and levocetirizine were negative. In view of the positive reactions obtained with the patch test and the oral accidental provocation test, the diagnosis of hydroxyzine-induced baboon syndrome was confirmed. The patient restarted his treatment with meprobamate without any incident.

![Sharply demarcated V-shaped erythema in the inguinal/perigenital area](IJD-58-244a-g001){#F1}

![V-shaped erythema on the higher part of the thighs and buttocks](IJD-58-244a-g002){#F2}

![Positive (++) reaction with pustules to Atarax® (30% pet.) at D4](IJD-58-244a-g003){#F3}

Discussion {#sec1-3}
==========

Drug-related baboon syndromes are very rare. According to Häusermann, *et al*.,\[[@ref2]\] about 50 cases of drug-related baboon syndrome have been reported in the literature. Recently, Häusermann, *et al*.\[[@ref2]\] proposed in 2004 a new acronym: Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) to replace and further refine the old term of drug-related baboon syndrome. They proposed five diagnostic criteria for SDRIFE: (1) Exposure to a systemically administered drug either at the first or repeated dose (excluding contact allergens); (2) sharply demarcated erythema of the gluteal/perianal area and/or V-shaped erythema of the inguinal/perigenital area; (3) involvement of at least another intertriginous/flexural localization; (4) symmetry of affected areas; and (5) absence of systemic symptoms and signs.\[[@ref2]\] Our patient fulfilled all these criteria.

Hydroxyzine is a first-generation histamine HI-antagonist. Hydroxyzine-induced drug eruptions are rarely reported. A review of literature identify only 17 reported cases of hydroxyzine-induced drug eruptions.\[[@ref6]--[@ref16]\] They include mainly maculopapular eruption (eight cases)\[[@ref7][@ref8][@ref10][@ref10]--[@ref15]\] and fixed drug eruption (seven cases).\[[@ref6][@ref9][@ref12]\] Urticaria\[[@ref11]\] and acute generalized exanthematous pustulosis\[[@ref16]\] have been reported each in one case.

Despite the structural similarity of the three anti-histamines, hydroxyzine, cetirizine, and levocetirizine, cross-reactions among them are rarely reported.\[[@ref13]\] In our case, patch tests and oral provocation tests with cetirizine and levocetirizine remained negative.

To the best of our knowledge, our case seems to be the first reported case of hydroxyzine-induced SDRIFE.

**What is new?**

To the best of our knowledge, we report here the first case of hydroxyzine-induced SDRIFE.
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